Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

G. Douglas Cole


  • Director at Denali Therapeutics Inc. (DNLI), 2017-12-08
  • Director at Quanterix Corp (QTRX), 2017-12-07
  • Director at Editas Medicine Inc. (EDIT), 2017-08-21
  • Director at Agios Pharmaceuticals Inc (AGIO), 2016-08-11
  • Director at Receptos Inc. (RCPT), 2013-07-20
  • Director at Tetraphase Pharmaceuticals Inc (TTPH), 2013-05-20
  • Director at Aveo Pharmaceuticals Inc (AVEO), 2011-05-16
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AVEO $17.98 49,500 Director 395,565 2011-05-16 Filing
AVEO $17.98 2,992 Director 23,909 2011-05-16 Filing
AVEO $17.75 76,750 Director 445,065 2011-05-13 Filing
AVEO $17.75 4,639 Director 26,901 2011-05-13 Filing
AVEO $17.30 15,200 Director 521,815 2011-05-12 Filing